Thirty-nine patients with nickel allergy as diagnosed by results of cl
inical history and intradermal testing with nickel sulfate were treate
d by sublingual hyposensitization. Intradermal testing was accurate an
d titration showed the degree of sensitivity. The immunologic principl
e of oral tolerance was used in treatment. Eighty-five percent of the
thirty-nine patients showed subjective improvement in their dermatitis
and all showed objective evidence of decreased intradermal sensitivit
y. None of the patients' conditions worsened. The use of oral treatmen
t with nickel sulfate deserves broader clinical trial.